inclusion criteria: - confirmed diagnosis of sars-cov-2 disease, detected by pcr or antigen test, performed 72 h prior to patient inclusion in the study. - acceptance to sign the informed consent document. - possession of a smartphone or tablet with internet connection. - possession of mental faculties to participate in the study.

inclusion criteria: - confirmed diagnosis of sars-cov-2 disease, detected by pcr or antigen test, performed 72 h prior to patient inclusion in the study. - acceptance to sign the informed consent document. - possession of a smartphone or tablet with internet connection. - possession of mental faculties to participate in the study.